<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201022049110N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-02-27</date_registration>
      <primary_sponsor>Bojnourd University of Medical Sciences</primary_sponsor>
      <public_title>Effect of resistance exercise using TheraBand on balance, timed up and go, and fear of fall in  elderly diabetic type 2 patients with peripheral neuropathy</public_title>
      <acronym></acronym>
      <scientific_title>Effect of resistance exercises using TheraBand on balance, timed up and go, and fear of fall in diabetic type 2 patients with peripheral neuropathy referring to Iranian diabetes foundation, in the city of Mashhad, 2020</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52101</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Before identifying the eligible participants, 60 random codes in the form of permuted random blocks with different sizes of  2, 4, and 6 for two equal groups will be generated by the software. Then each participants will be given a unique code on their enrolment, and finally they will be allocated to the intervention and control groups based on their random codes. At online software ( https://www.sealedenvelope.com) will be used for permuted block randomization.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Balance impairment due to Diabetic type 2 peripheral neuropathy.</hc_freetext>
      <i_freetext>Intervention 1: Participants in intervention group will perform resistance exercises using TheraBand, four days a week, 30 minutes each day, for twelve weeks. In the first six weeks red TheraBand (weak resistance) and in the last six weeks, green TheraBand (medium resistance) will be used.  Exercises include hip flexion and extension, hip adduction and abduction, knee flexion and extension, ankle dorsiflexion, and ankle flexion inward and outward. All movements will be perform in standing and sitting positions. Each movement  will be in 3 sets with 10 repetitions. Participants will pause for 2 to 3 seconds between repetitions, 1 to 2 minutes between sets and 2 to 3 minutes between different exercises. Intervention 2: Participants in intervention group will perform resistance exercises without using TheraBand, four days a week, 30 minutes each day, for twelve weeks. Exercises include hip flexion and extension, hip adduction and abduction, knee flexion and extension, ankle dorsiflexion, and ankle flexion inward and outward. All movements will be perform in standing and sitting positions. Each movement  will be in 3 sets with 10 repetitions. Participants will pause for 2 to 3 seconds between repetitions, 1 to 2 minutes between sets and 2 to 3 minutes between different exercises.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saeedeh Baghizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bojnurd School of Nursing and Midwifery, Shahriar St.</address>
        <city>Bojnurd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7487794149</zip>
        <telephone>+98 58 3222 1910</telephone>
        <email>s.baghizadeh@nkums.ac.ir</email>
        <affiliation>Bojnourd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mohammad Reza Armat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bojnurd School of Nursing and Midwifery, Shahriar St.</address>
        <city>Bojnurd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7487794149</zip>
        <telephone>+98 58 3222 1910</telephone>
        <email>armat@nkums.ac.ir</email>
        <affiliation>Bojnourd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having diabetes type 2
Having peripheral neuropathy with Endocrinologist diagnosis
Have physician's permission for exercise
Having caregiver during exercises
Gaining balance score less than 25 based on the Fullerton Advanced Balance Scale; and less than 32 based on Berg Balance Scale
Age between 60-75 years</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Gaining score less than 12 in scale for measuring activities of daily living
Having diabetic foot ulcer with physician's confirmation
Having vision problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R26.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other abnormalities of gait and mobility</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Participants in intervention group will perform resistance exercises using TheraBand, four days a week, 30 minutes each day, for twelve weeks. In the first six weeks red TheraBand (weak resistance) and in the last six weeks, green TheraBand (medium resistance) will be used.  Exercises include hip flexion and extension, hip adduction and abduction, knee flexion and extension, ankle dorsiflexion, and ankle flexion inward and outward. All movements will be perform in standing and sitting positions. Each movement  will be in 3 sets with 10 repetitions. Participants will pause for 2 to 3 seconds between repetitions, 1 to 2 minutes between sets and 2 to 3 minutes between different exercises.</i_keyword>
      <i_keyword>Participants in intervention group will perform resistance exercises without using TheraBand, four days a week, 30 minutes each day, for twelve weeks. Exercises include hip flexion and extension, hip adduction and abduction, knee flexion and extension, ankle dorsiflexion, and ankle flexion inward and outward. All movements will be perform in standing and sitting positions. Each movement  will be in 3 sets with 10 repetitions. Participants will pause for 2 to 3 seconds between repetitions, 1 to 2 minutes between sets and 2 to 3 minutes between different exercises.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance score in elderly with diabetic peripheral neuropathy. Timepoint: Study onset, weeks 4, 8, 12, and 16. Method of measurement: Using Fullerton advanced balance scale; and Berg balance scale.</prim_outcome>
      <prim_outcome>Timed up and go in elderly with diabetic peripheral neuropathy. Timepoint: Study onset, weeks 4, 8, 12, and 16. Method of measurement: Implementing timed up and go test.</prim_outcome>
      <prim_outcome>Fear of fall in elderly with diabetic peripheral neuropathy. Timepoint: Study onset, weeks 4, 8, 12, and 16. Method of measurement: Use of short form of International Fall Efficacy Scale (IFES).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bojnourd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-06</approval_date>
        <contact_name>Ethics committee of North Khorasan University of Medical Sciences</contact_name>
        <contact_address>Central Building of North Khorasan University of Medical Sciences, Dolat Blvd, Bojnurd Bojnurd North Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
